Immunotech Laboratories (IMMB) Stock Statistics & Valuation Metrics
Total Valuation
Immunotech Laboratories has a market cap or net worth of $114.99K. The enterprise value is ―.
- Market Cap
- $114.99K
- Enterprise Value
- ―
Share Statistics
Immunotech Laboratories has 574,965,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 574,965,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Immunotech Laboratories’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- 0
- Profits Per Employee
- -123.26K
- Employee Count
- 4
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Immunotech Laboratories had revenue of 0 and earned -493.03K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- -305.55K
- Operating Income
- -470.36K
- Pretax Income
- -493.03K
- Net Income
- -493.03K
- EBITDA
- -454.01K
- Earnings Per Share (EPS)
- 0.00
Stock Price Statistics
- Beta
- 0.18
- 52-Week Price Change
- 250.00%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Taxes
In the past 12 months, Immunotech Laboratories has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- ―
Analyst Forecast
The average price target for Immunotech Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
